DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

LinksClose Window

References

Slamon DJ, Eiermann W, Robert NJ. et al.
Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer. SABCS 2015; Abstr. S5-04.

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.